Breaking News !!!
Helsinki, Finland and Paris, France – April 12, 2013
The new Mobidiag to offer integrated, high-multiplex diagnostic tests for infectious diseases
Genewave is a development-stage diagnostics company whose mission is to provide information rapidly to curb the spread of hospital-acquired infections and anti-microbial resistance.
We are developing a small-footprint, inexpensive, and automated diagnostic instrument that will quickly deliver patient-specific information on 50+ genetic markers. With our on-chip, high-multiplex approach, we expect to offer a higher-performing, lower-cost, and more versatile solution versus bacterial culture and competing approaches in development.